Indeed, our results confirm that antibody-mediated inhibition of CD82 in leukemia cells interferes with DNA hypermethylation of the PTEN promoter region, and is associated with a decrease in both the level of H3K27me3 and the amount of EZH2 bound to the promoter. This evidence concerns the gene CD82 and leukemia.